Key result
Palliative care significantly improved 6-month Kansas City Cardiomyopathy Questionnaire scores in men (68.0 vs 41.1; P=0.047) but not in women (P=0.39) with advanced heart failure.
Why the study?
Palliative care improves quality of life in heart failure, but whether men and women derive similar benefit remains unknown.
Does palliative care intervention improve quality of life in men and women with advanced heart failure?
RCT (n=150)
Does palliative care intervention improve quality of life in men and women with advanced heart failure?
Absolute Event Rate: 68% vs 41.1%
p-value: p=0.047 (men); 0.39 (women)
Palliative care interventions in advanced heart failure may improve quality of life more in men than in women, suggesting a need for sex-specific approaches.
Palliative care was associated with sex-specific quality-of-life gains in advanced heart failure; hypothesis-generating and requires randomized confirmation before practice change.
Background: Palliative care improves quality of life in patients with heart failure. Whether men and women with heart failure derive similar benefit from palliative care interventions remains unknown. Methods: In a secondary analysis of the PAL-HF trial (Palliative Care in Heart Failure), we analyzed differences in quality of life among men and women with heart failure and assessed for differential effects of the palliative care intervention by sex. Differences in clinical characteristics and quality-of-life metrics were compared between men and women at serial time points. The primary outcome was change in Kansas City Cardiomyopathy Questionnaire score between baseline and 24 weeks. Results: Among the 71 women and 79 men, there was a significant difference in baseline Kansas City Cardiomyopathy Questionnaire (24.5 versus 36.2, respectively; P =0.04) but not Functional Assessment of Chronic Illness Therapy-Palliative Care scale (115.7 versus 120.3; P =0.27) scores. Among those who received the palliative care intervention (33 women and 42 men), women’s quality-of-life score remained lower than that of men after enrollment. Treated men’s scores were significantly higher than those untreated (6-month Kansas City Cardiomyopathy Questionnaire, 68.0 [interquartile range, 52.6–85.7] versus 41.1[interquartile range, 32.0–78.3]; P =0.047), whereas the difference between treated and untreated women was not significantly different ( P =0.39). Rates of death and rehospitalization, as well as the composite end point, were similar between treated and untreated women and men. Conclusions: In the PAL-HF trial, women with heart failure experienced a greater symptom burden and poorer quality of life as compared with men. The change in treated men’s Kansas City Cardiomyopathy Questionnaire score between baseline and 24 weeks was significantly higher than those untreated; this trend was not observed in women. Thus, there may be a sex disparity in response to palliative care intervention, suggesting that sex-specific approaches to palliative care may be needed to improve outcomes. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT0158960.
No takes yet. Share an insight, caveat, or question.
Truby et al. (2020) conducted an RCT in Advanced Heart Failure (n=150). Palliative care vs. Untreated (usual care) was evaluated on Change in Kansas City Cardiomyopathy Questionnaire score between baseline and 24 weeks (p=0.047 (men); 0.39 (women)). Palliative care significantly improved 6-month Kansas City Cardiomyopathy Questionnaire scores in men (68.0 vs 41.1; P=0.047) but not in women (P=0.39) with advanced heart failure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: